BioStable Science & Engineering
Austin, US · Delaware corporation · 1 known investors
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.
Founders & leadership
JW
John WheelerNamed on SEC filing
JC
Joe CunninghamNamed on SEC filing
DA
David AdairNamed on SEC filing
DS
David StrongNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 1 round · 2020
▶$4.2MraisedMar 2020 · 9 investors · Other TechnologyRule 506(b)
▶$4.2MraisedMar 2020 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John WheelerExecutive Officer, Director
- Joe CunninghamDirector
- David AdairDirector
- David StrongDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does BioStable Science & Engineering do?
- Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.
- Who are BioStable Science & Engineering's investors?
- BioStable Science & Engineering's investors include Rex Health Ventures.
- How much funding has BioStable Science & Engineering raised?
- BioStable Science & Engineering has disclosed $4.2M raised across 1 round.
- Where is BioStable Science & Engineering headquartered?
- BioStable Science & Engineering is headquartered in Austin, US.